Grallert, H. ; Dupuis, J.* ; Bis, J.C.* ; Dehghan, A.* ; Barbalic, M.* ; Baumert, J.J. ; Lu, C.* ; Smith, N.L.* ; Uitterlinden, A.G.* ; Roberts, R.* ; Khuseyinova, N.* ; Schnabel, R.B.* ; Rice, K.M.* ; Rivadeneira, F.* ; Hoogeveen, R.C.* ; Fontes, J.D.* ; Meisinger, C. ; Keaney, J.F.* ; Lemaitre, R.* ; Aulchenko, Y.S.* ; Vasan, R.S.* ; Ellis, S.* ; Hazen, S.L.* ; van Duijn, C.M.* ; Nelson, J.J.* ; Marz, W.* ; Schunkert, H.* ; McPherson, R.M.* ; Stirnadel-Farrant, H.A.* ; Psaty, B.M.* ; Gieger, C. ; Siscovick, D.* ; Hofman, A.* ; Illig, T. ; Cushman, M.* ; Yamamoto, J.F.* ; Rotter, J.I.* ; Larson, M.G.* ; Stewart, A.F.* ; Boerwinkle, E.* ; Witteman, J.C.* ; Tracy, R.P.* ; Koenig, W.* ; Benjamin, E.J.* ; Ballantyne, C.M.*
Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: Meta-analysis of genome-wide association studies from five community-based studies.
Eur. Heart J. 33, 238-251 (2012)
AIMS: Lipoprotein-associated phospholipase A2 (Lp-PLA2) generates proinflammatory and proatherogenic compounds in the arterial vascular wall and is a potential therapeutic target in coronary heart disease (CHD). We searched for genetic loci related to Lp-PLA2 mass or activity by a genome-wide association study as part of the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium. METHODS AND RESULTS: In meta-analyses of findings from five population-based studies, comprising 13 664 subjects, variants at two loci (PLA2G7, CETP) were associated with Lp-PLA2 mass. The strongest signal was at rs1805017 in PLA2G7 [P = 2.4 × 10(-23), log Lp-PLA2 difference per allele (beta): 0.043]. Variants at six loci were associated with Lp-PLA2 activity (PLA2G7, APOC1, CELSR2, LDL, ZNF259, SCARB1), among which the strongest signals were at rs4420638, near the APOE-APOC1-APOC4-APOC2 cluster [P = 4.9 × 10(-30); log Lp-PLA2 difference per allele (beta): -0.054]. There were no significant gene-environment interactions between these eight polymorphisms associated with Lp-PLA2 mass or activity and age, sex, body mass index, or smoking status. Four of the polymorphisms (in APOC1, CELSR2, SCARB1, ZNF259), but not PLA2G7, were significantly associated with CHD in a second study. CONCLUSION: Levels of Lp-PLA2 mass and activity were associated with PLA2G7, the gene coding for this protein. Lipoprotein-associated phospholipase A2 activity was also strongly associated with genetic variants related to low-density lipoprotein cholesterol levels.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
Genome-wide association; Inflammation; Lipoprotein-associated phospholipase A2
Keywords plus
Language
english
Publication Year
2012
Prepublished in Year
HGF-reported in Year
2012
ISSN (print) / ISBN
0195-668X
e-ISSN
1522-9645
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 33,
Issue: 2,
Pages: 238-251
Article Number: ,
Supplement: ,
Series
Publisher
Oxford University Press
Publishing Place
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30501 - Systemic Analysis of Genetic and Environmental Factors that Impact Health
Research field(s)
Genetics and Epidemiology
PSP Element(s)
G-504200-002
G-504100-001
Grants
Copyright
Erfassungsdatum
2012-02-27